Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Radiographics ; 42(2): 522-540, 2022.
Article de Anglais | MEDLINE | ID: mdl-35119966

RÉSUMÉ

The external ear (EE) is an osseous-cartilaginous structure that extends from the auricle to the tympanic membrane. It is divided into two parts: the auricle (or pinna) and the external auditory canal (EAC). Given the ease of access to the EE, imaging studies are not always needed to make a diagnosis. However, when lesions block visual access to areas deep to the EE abnormality, complications are suspected, or there is lack of response to treatment, imaging becomes essential. A basic understanding of the embryologic development and knowledge of the anatomy of the auricle and EAC are useful for accurate diagnosis of EE lesions. Congenital, traumatic, inflammatory, neoplastic, and vascular conditions can affect the EE. An overview of the anatomy and embryologic development of the EE is presented, with discussion and illustrations of common and uncommon conditions that affect EE structures and a focus on the CT and MRI features that are of interest to radiologists. CT is usually the first diagnostic modality used to evaluate the EAC and is the superior method for demonstrating bone changes. MRI provides excellent tissue characterization and enables one to better define lesion extension and perineural tumor spread. In addition, a flowchart to facilitate the differential diagnosis of EE abnormalities is provided. Online supplemental material is available for this article. ©RSNA, 2022.


Sujet(s)
Conduit auditif externe , Imagerie par résonance magnétique , Diagnostic différentiel , Conduit auditif externe/malformations , Conduit auditif externe/imagerie diagnostique , Conduit auditif externe/anatomopathologie , Humains
2.
J Cosmet Dermatol ; 20(9): 2860-2866, 2021 Sep.
Article de Anglais | MEDLINE | ID: mdl-33538111

RÉSUMÉ

BACKGROUND: M89 M (Mineral 89 mask, Laboratoires Vichy, France), containing 89% Vichy volcanic mineralizing water and hyaluronic acid, aims to strengthen and repair skin barrier. AIMS: To assess the efficacy, tolerance, patient satisfaction, and quality of life (QOL) using M89 M after laser procedures (LP). METHODS: M89 M was applied immediately post-LP for 10 minutes, then daily for 5 days and 2-3 times a week, up to 28 days on the faces of 51 women. Evaluations were performed immediately post-LP, immediately after M89 M application at D0, D1, D5, and D28, and included criteria such as erythema and skin dryness. Subjects scored burning and warm sensations, itching, skin tightness, and stinging. Skin hydration using a Corneometer, skin barrier integrity using a Tewameter, and erythema using a Chromameter were assessed. Local tolerance and adverse events were recorded. After 28 days, subjects answered a questionnaire regarding the M89 M subjective cosmetic properties and QOL. RESULTS: All subjects were in their mid-forties with a phototype of II, III, or IV. M89 M significantly (P < .001) reduced the immediate cutaneous discomfort sensation and laser procedure-related symptoms (burning, warmth sensation, itching/stinging, skin tightness). Skin hydration, and erythema, assessed using instrumental measures, were also significantly improved immediately after mask application (P ≤ .01). Subjects highly appreciated M89 M and their QOL improved after 28 days of use. Local tolerance was good to excellent in both studies. CONCLUSION: M89 M is effective and safe immediately after esthetic procedures such as ablative and nonablative lasers and also improves the subject's QOL.


Sujet(s)
Acide hyaluronique , Qualité de vie , Érythème/étiologie , Face , Femelle , Humains , Eau
3.
Pediatr Radiol ; 50(6): 776-792, 2020 05.
Article de Anglais | MEDLINE | ID: mdl-31925460

RÉSUMÉ

Pediatric multiple sclerosis (MS) deserves special attention because of its impact on cognitive function and development. Although knowledge regarding pediatric MS has rapidly increased, understanding the peculiarities of this population remains crucial for disease management. There is limited expertise about the efficacy and safety of current disease-modifying agents. Although pathophysiology is not entirely understood, some risk factors and immunological features have been described and are discussed herein. While the revised International Pediatric MS Study Group diagnostic criteria have improved the accuracy of diagnosis, the recently revised McDonald criteria also offer some new insights into the pediatric population. It is fundamental that radiologists have strong knowledge about the vast spectrum of demyelinating disorders that can occur in childhood to ensure appropriate diagnosis and provide early treatment.


Sujet(s)
Sclérose en plaques/imagerie diagnostique , Âge de début , Enfant , Diagnostic différentiel , Humains
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE